Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital, Tours
National Cancer Institute (NCI)
Pfizer
University of Cadiz
The University of Hong Kong
Guangdong Provincial People's Hospital
Fred Hutchinson Cancer Center
University of Washington
On Target Laboratories, LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Zhejiang University
Sun Yat-sen University
University of Utah
University of Mississippi Medical Center
University of Illinois at Chicago
Fuzhou General Hospital
Medical University of South Carolina
Henry Ford Health System
Convalife (Shanghai) Co., Ltd.
Henan Cancer Hospital
Aarhus University Hospital
National Taiwan University Hospital
Roswell Park Cancer Institute
Dana-Farber Cancer Institute
Guangzhou Concord Cancer Center
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Hacettepe University
OHSU Knight Cancer Institute
Massachusetts General Hospital
The First Affiliated Hospital of Guangzhou Medical University
Hanoi Medical University
University of Zurich
University of Maryland, Baltimore
SWOG Cancer Research Network
NHS Greater Glasgow and Clyde
Chung Shan Medical University
St. Joseph's Healthcare Hamilton
VA Office of Research and Development
UNC Lineberger Comprehensive Cancer Center
HealthPartners Institute
Guangzhou Medical University
Massachusetts General Hospital
Second Life Therapeutics
University Hospital, Brest
Avistone Biotechnology Co., Ltd.
Centre Hospitalier Henri Duffaut - Avignon
University of Edinburgh
Cancer Institute and Hospital, Chinese Academy of Medical Sciences